
Arndt Vogel
@arndtvogel
Clinician-scientist, focused on liver cancer & precision oncology, Toronto General Hospital/Princess Margaret Cancer Center 🇨🇦/MHH🇩🇪
ID: 1211086357
23-02-2013 08:40:33
1,1K Tweet
6,6K Followers
440 Following

Bispecific antibodies: advancing precision oncology Trends in Cancer doi.org/10.1016/j.trec… 👉Bispecific antibodies are on the rise with promising data 👏Excellent in depth review ESMO - Eur. Oncology
